Global Guillain-Barre Syndrome Companies

This report lists the top Global Guillain-Barre Syndrome companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Guillain-Barre Syndrome industry.

Guillain-Barre Syndrome Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Global Guillain-Barre Syndrome Top Companies

  1. CSL Behring

  2. Takeda Pharmaceuticals

  3. Grifols

  4. Kedrion Biopharma

  5. Octapharma

*Disclaimer: Top companies sorted in no particular order

Global Guillain-Barre Syndrome Market Major Players

Global Guillain-Barre Syndrome Market Concentration

Global Guillain-Barre Syndrome Market Concentration

Global Guillain-Barre Syndrome Company List

  • CSL Limited

  • Takeda Pharmaceutical Company Limited

  • Grifols S A

  • Octapharma AG

  • Bayer AG

  • Kedrion Biopharma Inc

  • China Biologic Products Holdings Inc

  • Biotest AG

  • Annexon Inc.

  • Cellenkos inc.


Specific to Global Guillain-Barre Syndrome Market
Need More Details on Market Players and Competiters?
Download PDF

Guillain-Barre Syndrome Market Report Snapshots